{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:29:58Z","timestamp":1790789398556,"version":"4.1.0"},"reference-count":0,"publisher":"Ivyspring International Publisher","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Cancer"],"published-print":{"date-parts":[[2024]]},"DOI":"10.7150\/jca.88261","type":"journal-article","created":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T04:33:10Z","timestamp":1701750790000},"page":"54-67","source":"Crossref","is-referenced-by-count":26,"title":["Mucin1 as a potential molecule for cancer immunotherapy and targeted therapy"],"prefix":"10.7150","volume":"15","author":[{"given":"Xiaohan","family":"Tong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujing","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4137","container-title":["Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jcancer.org\/v15p0054.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T04:33:47Z","timestamp":1701750827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jcancer.org\/v15p0054.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":0,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.7150\/jca.88261","relation":{},"ISSN":["1837-9664"],"issn-type":[{"value":"1837-9664","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]}}}